Close Menu

NEW YORK – NeoGenomics said after the close of the market on Thursday that it has entered into a new $250 million, five-year senior secured credit agreement.

The agreement consists of a $100 million revolving credit facility, a $100 million initial term loan, and a $50 million delayed-draw term loan, which is available for 18 months.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.